FibroGen's IPO

FibroGen raised a round of funding on November 14, 2014. Investors include Public.

FibroGen is a biotechnology company focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs.…

Articles about FibroGen's IPO: